|
1.
|
Bevacizumab-induced atypical hemolytic uremic syndrome and treatment with eculizumab. MedStar authors:
- Alhaj-Moustafa, Muhamad
- Fitzpatrick, Kelly
- Pilla, Ravi
- Vakiti, Anusha
Year: 2019
Citation: - Journal of Oncology Pharmacy Practice. 25(4):1011-1015, 2019 Jun.
Institution:
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Medicine/General Internal Medicine
Medline publication type:
All authors: - Alhaj-Moustafa M, Fitzpatrick KW, Pilla R, Singh D, Vakiti A
|
|
2.
|
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study. MedStar authors:
- Alsaadi, Dana
- Charabaty, Aline
- Jennings, Joseph
Year: 2018
Citation: - Journal for Immunotherapy of Cancer. 6(1):142, 2018 Dec 05.
Institution: - MedStar Washington Hospital Center
Department: - Gastroenterology/Hepatology
Medline publication type:
All authors: - Abu-Sbeih H, Ali FS, Alsaadi D, Charabaty A, Gong Z, Jennings J, Luo W, Richards DM, Wang Y
|